| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.09 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |